Pharma Summit 2015

With payers tightening belts and a general call to improve access to and affordability of drugs across markets, it is time for the pharma industry to reconsider its position. Pharma needs to catch up with other industries and create cost savings as well as improve performance, whilst as overcoming the challenges of being a controlled consumer market.
How can pharma change to survive within present and future market requirements?

KEY TOPICS TO BE COVERED INCLUDE:
• What can pharma gain from being active in prevention as well as treatment?
• How is increased patient engagement impacting pharma?
• How can R&D be revolutionised in the interests of patients, payers and pharma?
• Where does the industry stand on biologics and biosimilars?
• What are the primary focus areas for pharma giants in emerging vs developed markets?
• How can pharma reduce costs whilst maintaining quality as well as meet business objectives and regulatory constraints?

Speakers:
Guido Rasi,Belen Garijo,Andrew Hotchkiss,Maureen Baker,Manica Balasegaram,Richard Barker,François Bernard,Sir Andrew Dillon,Patrick Flochel,Michel Goldman and many more...